August 14, 2023

CMVibe Study: Evaluates a CMV vaccine in healthy females or males aged 9-15 years old and healthy females aged 16-25 years old.

Congenital CMV infection is the most common infection passed from the mother to baby during pregnancy. It is also the most common non-hereditary cause of hearing loss and brain damage in children. You or your child will have 3 injections, several months apart. You will have approximately 11 clinic visits over the 18 month study period. Saliva swabs, urine, and blood samples will be required. Compensation for participation is available. To learn more, visit or contact the UAB study team: 205-638-2629 or